Biota Holdings
Encyclopedia
Biota is an Australian antiviral drug
development company listed on the Australian Stock Exchange
(ASX:BTA).
In 1989 Biota discovered the drug Zanamivir, which acts as a neuraminidase
inhibitor for the treatment and prevention of influenza
. This drug is licensed to GlaxoSmithKline
and marketed as Relenza.
Antiviral drug
Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics for bacteria, specific antivirals are used for specific viruses...
development company listed on the Australian Stock Exchange
Australian Stock Exchange
The Australian Securities Exchange was created by the merger of the Australian Stock Exchange and the Sydney Futures Exchange in July 2006. It is the primary stock exchange group in Australia....
(ASX:BTA).
In 1989 Biota discovered the drug Zanamivir, which acts as a neuraminidase
Neuraminidase
Neuraminidase enzymes are glycoside hydrolase enzymes that cleave the glycosidic linkages of neuraminic acids. Neuraminidase enzymes are a large family, found in a range of organisms. The most commonly known neuraminidase is the viral neuraminidase, a drug target for the prevention of the spread...
inhibitor for the treatment and prevention of influenza
Influenza
Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae , that affects birds and mammals...
. This drug is licensed to GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline plc is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom...
and marketed as Relenza.